ARCHIVES

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Virus Program Report On Scientific Activities

August 15, 1975

In Brief: Public Favors stronger Laws Restricting Teen Smoking; Anderson Expands Pediatric Studies

April 26, 1991

NCI Awards $59M Contract For Key Project To consolidate Phase III Trial Administration

October 29, 1999

House Plan Promises $3.5 Billion For NIH; Cooperative Groups May Get AHRQ Funds

January 23, 2009

In Brief: Donald Metcalf Wins Bristol-Myers Award; NCI Starts Search for Biological Carcinogenesis AD

May 1, 1987

NCCN Updates Myeloma Clinical Practice Guidelines

September 26, 2003